Next Article in Journal
Discovery and Development of Inhibitors of the Plasmodial FNT-Type Lactate Transporter as Novel Antimalarials
Next Article in Special Issue
Curcumin-Based β-Diketo Ligands for Ga3+: Thermodynamic Investigation of Potential Metal-Based Drugs
Previous Article in Journal
Targeting Oxidative Stress, NLRP3 Inflammasome, and Autophagy by Fraxetin to Combat Doxorubicin-Induced Cardiotoxicity
Previous Article in Special Issue
Recent Developments in the Synthesis of β-Diketones
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Structural Studies of β-Diketones and Their Implications on Biological Effects

Department of Science and Environment, Roskilde University, Universitetsvej 1, DK-4000 Roskilde, Denmark
Pharmaceuticals 2021, 14(11), 1189; https://doi.org/10.3390/ph14111189
Submission received: 20 October 2021 / Revised: 11 November 2021 / Accepted: 17 November 2021 / Published: 20 November 2021

Abstract

:
The paper briefly summarizes methods to determine the structure of β-diketones with emphasis on NMR methods. Density functional calculations are also briefly treated. Emphasis is on the tautomeric equilibria of β-diketones in relation to biological effects. Relevant physical parameters such as acidity and solubility are treated. A series of biologically active molecules are treated with respect to structure (tautomerism). Characteristic molecules or groups of molecules are usnic acids, tetramic and tetronic acids, o-hydroxydibenzoylmethanes, curcumines, lupulones, and hyperforines.

1. Introduction

β-Diketones can roughly be divided into three different groups, as shown in Figure 1. The three types are referred to as linear β-diketones (lbdk), cyclic β-diketones (cbdk), and double-bond β-diketones (dbdk). In addition, triketones are also included, as the diketone motif is present. Derivatives not containing the diketo part are not considered, as this will be too extensive and is also the case for metal complexes.
Linear β-diketones (lbdk) usually occur as a mixture of an enol-form and a diketo-form (Figure 1a), the former dominating. The enol-form shows two tautomers in fast exchange. The dominant tautomeric form is important for the biological activity. However, in this case, the barrier to interconversion between the enol and the keto-form is very important. In many papers, the different forms are not mentioned correctly or even not taken into account, which is critical when discussing biological effects. Important parameters in the discussion of biological effects are the ability of humans to take up the compounds as well as the excretion rate. Both parameters are closely related to structure.
β-Diketones can be obtained from natural sources such as plants, fungi, or bacteria, but can also be synthesized. The synthesis of the simple β-diketones is usually not complicated [1,2]. A number of reviews have discussed tautomerism and biological effects [3,4,5,6,7,8].
Arshad et al. [9] have published an extensive review on immunosuppressive effects of natural a,b-unsaturated carbonyl-based compounds, including β-diketones. Dibenzoylmethane, 3,3′,5′-trimethoxydibenzoylmethane, curcumin, didesmethoxycurcumin (bis-demethoxycurcumin), and the ethyl equivalent of curcumin (all given as the diketoform) were found to have strong immunosuppressive effects on granylocytes. Didesmethoxycurcumin and (2Z,4E)-1-(4-chloro-2-hydroxyphenyl)-5-(3,4-dimethoxyphenyl)-3-hydroxypenta-2,4-dien-1-one (Figure 2) were found to have strong immunosuppressive effects on monocytes and macrophages.

2. Structure Determination

2.1. NMR

Structure determination and the presence of tautomerism is very important in relation to biological effects. NMR is an indispensable tool. For a review covering early results, see [10]. Using NMR in the case of β-diketones, one should remember that the equilibrium between the diketo- and the enol-forms (Figure 1) is slow on the NMR scale, and therefore both forms can be observed, irrespective of the solvent, whereas the equilibrium between the two enol-forms is so fast that only an average NMR spectrum is observed. Both the use of chemical shifts and isotope effects on chemical shifts have been used. In the latter case, deuteration of the OH proton (chelate proton) is frequently used [11], but also 18O isotope effects have in a few cases proven useful [12]. For low-barrier hydrogen bonds, a characteristic feature is a very high frequency 1H chemical shift of the chelate proton, ≈15 ppm. However, this resonance can be absent if other OH groups are present, as seen in curcumins. A simple indicator of the presence of the diketo-fom is a 1H resonance with a chemical shift of ≈5.3 ppm, integrating 2H for the central CH2 group (see Table 1).
Besides 1H chemical shifts, 17O chemical shifts can also be used. In this case, one takes advantage of the large chemical shift difference between single-bonded and double-bonded oxygen. The use has been reviewed, but some disagreements about ranges exist [13,14]. Studies have also been performed in the solid state [15]. The hydrogen bond in curcumin (see Section 9) was studied by 17O NMR in the solid state, in combination with DFT plane wave calculations [16].
To determine the ratio between the two enolic forms, partial deuteration of the enol proton and measurement of deuterium isotope effects on 13C chemical shifts is a very useful tool. An example is seen in Figure 3 [11]. We see three different kind of isotope effects. The lower set of numbers is caused by deuteration at C-2. The fact that C-2 is deuterated is direct evidence that the keto-form and the enol-form are in equilibrium. The middle set of isotope effects is caused by deuteration at OH-2´. This effect is an indicator of hydrogen bond strength. These two types of isotope effects are the so-called intrinsic isotope effects. The top set of data are due to deuteration at the chelate OH group. The intrinsic isotope effect of this strong hydrogen bond is close to 0.5 ppm. However, the deuteration leads to a shift in the chemical equilibrium and therefore also to an equilibrium isotope effect [11]. Using the graph of [17], the mole fraction of the two enol-forms can now be determined.
Coupling constants involving the chelated proton may also be used. An example is the use of 2J(C,OH) in usnic acid (Figure 4).
The relevant two-bond couplings are 2J(C-11,OH) Hz = 3.5 Hz and 2J(C-3,OH) = 3.6 H, showing that the equilibrium is close to 50:50 [18]. This is also confirmed by the corresponding deuterium isotope effects on chemical shifts [17]. This technique is sensitive enough to monitor a change in the equilibrium caused by acylation of the OH group at position 9. In this case, the couplings are 2J(C-11,OH) = 3.7 Hz and 2J(C-3,OH) = 3.2 Hz.

2.2. IR

Sloop et al. [19] have investigated β-diketones with R1=CF3 and R2 = alkyl, aryl, heteroaromatic, and cyclic (Figure 1), and given a set of characteristic wavenumbers in order to identify the various tautomers. The diketo-form is 1687–1790 cm−1 with slight variations. The enol-form C=OCF3 is 1580–1640 cm−1, with the exception of cyclic compounds at 1550–1640 cm−1. For the other enol-form C=O-R, it is 1650–1700 cm−1. Benassi et al. [20] calculated frequencies for all four rotamers of curcumin, finding a good fit to the IR spectrum. In a similar way, the IR spectrum of glycosylated curcumin was analyzed, providing a good fit between experimental and calculated values using the B3LYP/6-311G(d) functional and basis set. The populations of the various rotamers were estimated on the basis of calculated ΔG values [21].

2.3. UV–VIS

Sloop et al. [19] provided ranges for UV–VIS absorptions of the diketo-form and of the two enol-forms of β-diketones in which R1 (Figure 1) is CF3. The spectrum of the diketo- and the enol-forms often overlap. The deconvolution can be achieved using chemometric methods. For a general description of the use of chemometric methods to analyze tautomeric systems based on UV-VIS spectra, see [22]. Mondal et al. [23] investigated the UV–VIS spectrum of curcumin in several solvents and solvent mixtures. In non-polar solvents, the absorbance is at 410–420 nm, whereas in water, it is at 427 nm. For the effect of water, see Section 3.

3. Ratios between Enol- and Diketo-Forms

The ratio between the diketo- and enol-forms varies with the substituents, R1, R2, and R3 (see Figure 1), but also with the polarity of the solvent. From Table 1, it is seen that the enol content increases as the size of R1 and R2 increases, whereas the diketo-form increases with the size of R3.
From Table 2, it is seen that with R1 and R2 substituents being aromatic or heteroaromatic, the enol content is close to 100%. A series of dibenzoylmethanes with substituent at the aromatic ring such as COOR or alkyl showed again a very high percentage of enol-form. The variation was from 93.1 to 99.9%. Furthermore, the variation in four different solvents such as DMSO-d6, acetone-d6, CDCl3, and benzene-d6 was moderate [19]. Sloop et al. [19] investigated β-diketones with R2=CF3. For R3 being very bulky or fluorine, the equilibrium is fully on the keto-form. For those molecules primarily on the enol-form, extended conjugation would favor the a-form. However, if substituents in o-position of the aromatic ring prevented coplanarity, this would favor the b-form and thus would intramolecular hydrogen bonding with substituents at R1. Finally, electron withdrawing substituents at the aromatic ring would also favor the b-form. Sloop et al. [19] claim that UV and IR are the preferred methods and that they are better than NMR, but this is only because they have used inadequate NMR methods. Had they used deuterium substitution, this would not be the case (see Section 2). With R1 and R2 equal to substituted double bonds as found in curcumins, the pattern is similar [25]. The influence of R3 is pronounced.
Bunting et al. have determined the equilibrium constant between the keto and the form in aqueous solution with the ionic strength of 0.1 at 25 °C, as seen in Table 3. It is obvious that the keto-form in most cases is dominant, contrary to organic solvents. However, the factors influencing the equilibrium constants seem to be the same [29]. The keto–enol equilibrium of curcumin in ethanol/water mixtures was investigated using UV–VIS spectroscopy. The amount of diketo-form is increasing with the increase in the water content [30]. The same trend is found in DMSO–water mixtures (see Figure 5).
For avobenzone 1-(4-(tert-butyl)phenyl)-3-(4-methoxyphenyl)propane-1,3-dione, R1 = 4-terbutylphenyl, and R2 = 4-methoxyphenyl, as shown in Figure 1, and the amount of diketo-form can be increased in chloroform from 4 to 10% if the central carbon is dideuterated [31].

4. Interconversion between Tautomers

Interconversion between the two enol-forms is very fast due to the very low barrier. It has never been possible to observe the two enol-forms separately by NMR, but they can be measured by femtosecond absorption in the ultraviolet range [32]. However, the interconversion between the enol and the keto-form is slow on the NMR time scale. The barrier for interconversion for acetylacetone has been calculated as 62 Kcal, but with water present, it was ≈30 Kcal [33]. Conradie et al. [26] determined the first-order rate constant for conversion of the enol to keto-form for R1 = R2 = 2-thienyl as 3.1 × 10−5 s−1 and for R1 = 2-thienyl and R2 = phenyl as 2.6 × 10−6 s−1. Katritzky et al. [3] discussed general rules for observing the two tautomers. Obviously, if the rate is slow compared to the biological time scale, both tautomers should be considered separately. However, if it is fast, it does not really matter.

5. pKa Values

Bunting et al. have determined pKa values for a large series of β-diketones for both the keto- and the enol-forms and the equilibrium constant in aqueous solution with ionic strength of 0.1 at 25 °C. The pKa values for the two forms are not very different (see Table 3) [29]. Furthermore, only with pyridyl substituents are the pKa values below the physiological pH of 7.4. In this case, a substantial amount of the anion can be expected in the blood. For enols at the anion form, a different conformation with the two oxygens “trans” can be expected. For triketones, the pKa values are even lower, and an example is usnic acid with a pKa value of 4.4 [34] In pegylated usnic acid, the pKa in a mixture of H2O and DMSO was determined as 4.3 [5].

6. Inclusion Complexes

A study related to drug delivery is the study of benzoylacetone enclosed into β-cyclodextrin. Iglesias et al. [35] found that the planar enol-form protruded deeper into the cyclodextrin cavity, and this way leads to more enol-form (see Figure 6). For the less planar diketo-form, only the phenyl ring is buried. Strangely enough, the diketo-form is drawn with the two oxygens on the same side. A hydrogen bond from the rim to the keto group is also suggested.
Inclusion of curcumin has been used to a large extent. Angelova and Antonov have studied the inclusion in calixarenes both experimentally [36] and theoretically [37]. In the latter case, they found that both tautomeric forms can enter and leave the host cavity without sterical problems and that the diketo-form was favored.

7. Density Functional Calculations

Density functional calculations (DFT) are very useful in the study of compounds in solution. DFT calculations can be performed at many levels and provide a variety of details about structure, NMR, IR, UV parameters, and energy, etc. In the present author’s opinion, a “cheap” solution, referring to memory requirements and computational time, such as B3LYP/6-31G(d) [38], can often provide useful results in cases of NMR and IR calculations. An example is the calculation of the often elusive OH stretching frequencies of β-diketones [39,40], but also NMR parameters such as chemical shifts, isotope effects on chemical shifts, and coupling constants can be calculated in a satisfactory way for β-diketones [41]. A higher basis set was used for curcumin derivatives such as 6-311++G(2d,p) [42]. To calculate UV–VIS spectra, Benassi et al. used B3LYP/6-311G(d,p) [20], whereas Puglisi et al. used M06-2X/def2-TZVP functional and basis set [43].
Caruso et al. [44] compared X-ray data and DFT data for 4-benzoyl-3-methyl-1-phenylpyrazol-5-one (see Figure 7) and found especially for the diketo-form an excellent agreement between structures determined by X-ray and calculated structures. The effect of water was taken into account using the COSMO algorithm [45]. DFT calculations were used to discuss the structure of 4-furancarbonyl, 4-t-butylcarbonyl, 4-(3-cyclopentylpropanoyl), and 4-tert-butylacetyl of 3-methyl-1-phenylpyraxol-5-ones.

8. Docking Studies

Caruso et al. [44] docked HQPh to the ICAM-1 protein and found that the keto–enol-form acted better than the diketo-form. For the docked structure (see Figure 7, top), the obtained inhibition was 75%. The highest binding energy for the four tautomers shown in Figure 8 is that of d. However, the one docked is that of b (Figure 7, top), as that of d is not present to any large extent in water. Porchezhiyan et al. [46] synthesized a large series of L-proline-based β-diketones (Figure 7, bottom). They found that the derivative with R = 6-methoxynaphthalene showed anti-cancer activity. Docking of the compounds shown in Figure 7 towards COX-1 and COX-2 was performed using the protein crystal structures of PDB ID: 1HT5 in order to evaluate the anti-inflammatory activity. Dhoke et al. [47] developed docking procedures for, among other diketones, 2,4-pentanedione and 3,5-heptanedione. These were docked as the diketo-form. As shown in Table 1, they exist primarily as the keto–enol-form. Zusso et al. [48] docked curcumin, bis-demethoxycurcumin (Figure 2), and a cyclized pyrazole analogue (the β-diketone unit has been reacted with hydrazine). All three could bind into the LPS binding site of myeloid differentiation protein-2. Important interactions were hydrogen binding with Arg-90, Glu-92, and Tyr-102. However, only the two curcumins inhibited LPS-induced TLR4 dimerization, activation of NF-κB, and secretion of pro-inflammatory cytokines in primary microglia.

9. Structures

A general feature of β-diketones of type A (see Figure 1) is the apparent resemblance of the diketo-form and the enol-forms. However, this is only due to the traditional way of drawing. The diketo-form is more on a form with the two keto groups trans to each other.
In the following section, a number of structures are discussed in relation to their biological effects. Lupulone from hops soft resin showed two different enolic forms depending on solvent, as seen in Figure 9.
In cyclohexane, a 30:70 mixture of a/b exists, whereas in DMSO-d6, the compound is fully on form b. (-)-(R)-humulone (one R is an OH group, which is pointing inwards) and lupulone inhibit cell growth and induce caspase-dependent apoptosis [49]. A similar finding was uncovered for garciniaphenone and for 7-epi-clusianone (Figure 10). Both compounds show strong intramolecular hydrogen bonds. Both forms a and b could be observed in the 1H NMR spectrum (OH chemical shifts, 17.90 and 17.35 ppm). This means that the tautomeric exchange is rather slow. The two tautomers exist in a ratio of 5:1 for a/b [50]. The structure was also confirmed by an X-ray study [51]. A similar behavior was found for guttiferones A-E and clusianone [52,53]. Guttiferone A, a similar compound, shows HIV-inhibitory properties [54]. Guttiferone A, garciniaphenone, and 7-epiclusianone are discussed together with many other natural products as cathepsin inhibitors [55,56].
Caruso et al. [44] synthesized a large series of 3-methyl-1-phenylpyraxol-5-ones. The benzoyl derivative is shown in Figure 8. Other substituents were 4-furancarbonyl, 4-t-butylcarbonyl, 4-(3-cyclopentylpropanoyl), and 4-tert-butylacetyl. They were tested on the intercellular adhesion molecule-1 (ICAM-1). The best inhibition was obtained for the molecule in Figure 7. DFT calculations were performed, and c was found to have the lowest energy (Figure 8). However, both a and b are within 5 Kcal. The fact that c had the lowest energy is somewhat unusual, as it encloses an exocyclic double bond. Unfortunately, no interconversion barriers are known. HQPh is more active than its metal complexes.
An interesting structure that seems to cause diverse biological effects is shown in Figure 11.
This structural element is part of tetracyclines, and in this case, the equilibrium is shifted towards the a-form [8]. Furthermore, it has shown promising effects in comparison with mycobacteria [57]. 1-(2-Hydroxyphenyl)-3-phenyl-1,3-propanedione was shown to induce apoptosis in colorectal carcinoma COLO 205 cells. It is better than dibenzoylmethane and also better than the derivative of o-hydroxydibenzoylmethane with a methyl group in 5-position (R1 is CH3 in Figure 9). The mechanism is a complicated chain reaction starting with coordinative modulation of Cyclin D3, Bcl-XL and Bax, release of cyctochrome c, and sequential activation of caspases [58]. Furthermore, the derivative with R1 = H and R2 = o-OH shown in Figure 9 inhibited TPA-induced skin tumor promotion significantly [59]. However, there was no discussion about the tautomer being responsible for the action, and only a resemblance to aspirin is mentioned. o-Hydroxydibenzoylmethane is selectively cytotoxic against breast cancer MCF-7 cells [60].
Many recent reviews deal with curcumin [61,62,63,64]. Another recent review found that taking curcumin would increase the expression of anti-metastatic proteins [65]. Curcumin belongs to the Pan-Assay Interference Structures (PAINS) family [66]. In the present paper, only very recent papers are discussed specifically. Important features of curcumin are the existence of both diketo-form and enol-forms. A recent study [42] investigated a large series of curcumin analogues (Figure 12). Probabilities to act as antineoplastic, prostate cancer treatment, and anticarcinogenic agents was studied theoretically by applying a selection of quantitative structure–activity relationship and absorption, distribution, metabolism, and excretion (ADME) approaches. For the compounds, the enol-form is generally the more effective. They are good against prostate cancer (see Figure 13). With regard to substituents, the more OH and OCH3 groups, the better.
The degradation of curcumin leads to a number of products, some of which could be important for biological action. However, only glucosidation maintains the β-diketone structure [67,68,69]. In terms of action, it has been found that the presence of piperidine from, e.g., black pepper increases the effect, but this is an indirect effect as piperidine decreases the degradation rate [70].
Tetronic acids, tetramic acids, and 3-acylderivatives are found frequently in nature. An early review was given by Schobert and Schlenk [71]. The 3-acyl derivatives are triketones. Two-sets of tautomeric equilibria exist, as seen in Figure 14. An efficient way of analyzing such systems is the use of deuterium isotope effects [6,72]. A recent example is the isolation of penicillenol A1 and A2 (R=C(OH)CH3 and R1 = 1-methylhexyl and R2 = CH3) from the sponge P. fusca Thiele [73] and also from a deep see fungus, Aspergillus restrictus. The penicillenols are active against Candida albicans biofilm formation. A structure–bioactivity relationship study suggested that the saturation of hydrocarbon chain at C-8, R-configuration of C-5, and trans-configuration of the double bond between C-5 and C-6 of the pyrrolidine-2,4-dione unit were important for their anti-biofilm activities [74].
A recent paper discussed synthesis based on catalysis. Interesting examples are reutericyclin (Figure 14) and other examples given in [75]. Again, reutericyclin is depicted as the a-form (Figure 15), whereas it is the b-form that is active. A SAR study showed that lipophilic analogs were best against Gram-positive bacteria [76].
Tetramic acid is also combined with ampicillin to form a hybrid in order to improve the effect against Gram-negative bacteria [77].
The dihydroanthracen-1(4H) one (Figure 16) isolated from Rubia philippinensis is an inhibitor of soluble epoxide hydrolase (sEH). The structure was given as a single tautomer [68] but has been suggested to exist as a tautomeric equilibrium [8].
From St. John´s wort (Hypericum perforatum), a number of active compounds have been isolated. One of these being hyperforin (Figure 17), which has antidepressant properties [79], as well as adhyperforin [80]. Simple prenylated compounds were also synthesized and show activity.
Two β-diketones have attracted a large amount of attention over the years, namely, usnic acid (see Figure 4) and tetracyclines. A large number of usnic acid derivatives have been developed [81,82]. However, some of these are derivatized at the tri-ketone site. Usnic acid is not very water-soluble [83]. Attempts have been made to increase this. One way to is to make a polyamide complex. The polymer/drug complexes possess a greater antimicrobial activity against Staphylococcus epidermidis than usnic acid itself [84]. Another way is the Rop/Raft strategy [85]. Solubilization is also increased by the use of micellar solutions of N,N’-didecyl-N,N,N’,N’-tetramethylethane-1,2-diyldiammonium dibromide and decyl 2-[decyl(dimethyl)ammonio]ethylphosphate [86] or by used of graphene–usnic acid conjugate microspheres. The latter showed antibacterial activity against Staphylococcus aureus [87]. A simple approach is to attach a polyglycol to one OH group [5]. The use of a salt to increase solubility has also been suggested [88]. Considering the low pKa value of usnic acid [34], one would image that this would happen automatically. This leads to a discussion of the predominant form at physiological pH [5].

10. Conclusions

β-Diketones are characterized by an equilibrium between a keto form and an enol form (Figure 1). The interconversion between these two forms is usually slow, which means that from a biological point of view, the two forms may have widely different biological properties, especially as the conformations of the keto-form and the enol-form are different. The enol-forms are characterized by a very strong intramolecular hydrogen bond, keeping the structure with the two oxygens at the same side. In contrast, the keto-form will typically have the two C=O bonds in a “trans” orientation. The fact that the enol-form has a strong intramolecular hydrogen bond is usually not taken into account in programs predicting biological properties. Docking studies demonstrate the importance of a correct tautomer. The enol-form usually dominates in solvent with a low dielectric constant. The ratio of the enol- and the keto-forms can be regulated by substitution at the central carbon. Large substituents will favor the keto-form. In water, the equilibrium between keto- and enol-forms is shifted strongly towards the keto-form. The acidity of the OH proton is for most of the β-diketones not acidic enough to lead to an anionic structure. The β-diketones clearly have many biological functions, but the motif seems to be part of many different molecules with a variety of biological functions.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. Shokova, E.A.; Kim, J.K.; Kovalev, V.V. 1,3-Diketones. Synthesis and Properties. Russ. J. Org. Chem. 2015, 51, 755–830. [Google Scholar] [CrossRef]
  2. Pabon, H.J.J. A synthesis of curcumin and related compounds. Recl. Trav. Chim. Pays-Bas 1964, 83, 379–386. [Google Scholar] [CrossRef]
  3. Katritzky, A.R.; Hall, C.D.; El-Dien, B.; El-Gendy, M.; Draghici, B. Tautomerism in drug discovery. J. Comput. Aided Mol. Des. 2010, 24, 475–484. [Google Scholar] [CrossRef]
  4. Martin, Y.C. Lets not forget the tautomers. J. Comput. Aided Mol. Des. 2009, 23, 693–704. [Google Scholar] [CrossRef] [Green Version]
  5. Hansen, P.E.; Mortensen, J.; Kamounah, F.S. The importance of correct tautomeric structures for biological molecules. JSM Chem. 2015, 3, 1014–1019. [Google Scholar]
  6. Hansen, P.E. Tautomerism and biological activity of beta-diketones, triketones, beta, ketoesters and beta-ketoamides. A Mini Review. Wiad. Chem. 2017, 71, 428–444. [Google Scholar]
  7. Bukhari, A.N.S.; Jantan, I.B.; Jasamai, M.; Ahmad, W.; Amjad, M.W.B. Synthesis and Biologival Evaluation of Curcumin Analogues. J. Med. Sci. 2013, 13, 501–513. [Google Scholar] [CrossRef] [Green Version]
  8. Hansen, P.E. NMR of natural product as potential drugs. Molecules 2021, 26, 3763. [Google Scholar] [CrossRef] [PubMed]
  9. Arshad, L.; Jantan, I.; Bukhari, S.N.S.; Haque, M.A. Immunosuppressive Effects of Natural a,b-Unsaturated Carbonyl-Based Compounds, and Their Analogs and Derivatives, on Immune Cells: A Review. Front. Pharmacol. 2017, 8, 22. [Google Scholar] [CrossRef] [Green Version]
  10. Claramunt, R.M.; López, C.; Maria, M.D.S.; Sanz, D.; Elguero, J. The use of NMR spectroscopy to study tautomerism. Prog. Nucl. Magn. Reson. Spectrosc. 2006, 49, 169–206. [Google Scholar] [CrossRef]
  11. Hansen, P.E. Hydrogen-bonding and Tautomerism studied by Isotope Effects on Chemical Shifts. J. Mol. Struct. 1994, 321, 79–87. [Google Scholar] [CrossRef]
  12. Boykin, D.W. Applications of 17O NMR Spectroscopy to Natural Products Chemistry. In Studies in Natural Products Chemistry; Elsevier: Amsterdam, The Netherlands, 1995; Volume 17, pp. 549–600. [Google Scholar]
  13. Garbisch, E.W. Hydroxymethylene Ketone-aldo enol equilibrium. J. Am. Chem. Soc. 1963, 85, 1696–1697. [Google Scholar] [CrossRef]
  14. Bolvig, S.; Hansen, P.E.; Wemmer, D.; Williams, P. Deuterium Isotope Effects on 17O Chemical Shifts of Intramolecularly Hydrogen Bonded Systems. J. Mol. Struct. 1999, 509, 171–181. [Google Scholar] [CrossRef]
  15. Wu, G. Solid-State 17O NMR Spectroscopy of Organic and Biological Molecules. In Modern Magnetic Resonance; Webb, G.A., Ed.; Springer International Publishing AG: Berlin/Heidelberg, Germany, 2018; pp. 841–860. [Google Scholar] [CrossRef]
  16. Kong, X.; Brinkmann, A.; Terskikh, V.; Wasylishen, R.E.; Bernard, G.M.; Duan, Z.; Wu, Q.; Wu, G. Proton probability distribution in the O···H···O low-barrier hydrogen bond: A combined solid-state NMR and quantum chemical computational study of dibenzoylmethane and curcumin. J. Phys. Chem. B. 2016, 120, 11692–11704. [Google Scholar] [CrossRef] [PubMed]
  17. Bolvig, S.; Hansen, P.E. Deuterium Isotope Effects on 13C Chemical Shifts as a Probe for Tautomerism in Enolic β-Diketones. Magn. Reson. Chem. 1996, 34, 467–478. [Google Scholar] [CrossRef]
  18. Borisov, E.V.; Zhang, W.; Bolvig, S.; Hansen, P.E. nJ(C,OH) Coupling Constants of Intramolecularly Hydrogen Bonded Compounds. Magn. Reson. Chem. 1998, 36, S104–S110. [Google Scholar] [CrossRef]
  19. Sloop, J.C.; Bumgartner, C.L.; Wahington, G.; Loehle, W.D.; Sankar, S.S.; Lewis, A.B. Keto-enol and enol-enol tautomerism in trifluoro-β-diketones. J. Fluochem. 2006, 127, 780–786. [Google Scholar]
  20. Benassi, R.; Ferrari, E.; Lazzari, S.; Spagnolo, F.; Saladini, M. Theoretical study on Curcumin: A comparison of calculated spectroscopic properties with NMR, UV-vis and IR experimental data. J. Mol. Struct. 2008, 892, 168–176. [Google Scholar] [CrossRef]
  21. Benassi, R.; Ferrari, E.; Lazzari, S.; Pignedoli, F.; Spagnolo, F.; Saladini, M. How glucosylation triggers physical-chemical properties of curcumin: An experimental and theoretical study. J. Phys. Org. Chem. 2011, 24, 299–310. [Google Scholar] [CrossRef] [Green Version]
  22. Antonov, L. Absorption UV-Vis Spectroscopy and Chemometrics: From Quantitative Conclusions to Quantitative Analysis. In Tautomerism: Methods and Theories; Antonov, L., Ed.; Wiley-VCH: Weinheim, Germany, 2013. [Google Scholar]
  23. Mondal, S.; Ghosh, S.; Moulik, S.P. Stability of curcumin in different solvent and solution media: UV–visibleand steady-state fluorescence spectral study. J. Photochem. Photobiol. B Biol. 2016, 158, 212–218. [Google Scholar] [CrossRef] [PubMed]
  24. Schweitzer, G.K.; Benson, W. Enol Content of Some Beta-Diketones. J. Chem. Eng. Data 1968, 3, 454–455. [Google Scholar] [CrossRef]
  25. Pedersen, U.; Rasmussen, P.B.; Lawesson, S.-O. Synthesis of Naturally Occurring Curcuminoids and Related Compounds. Liebigs Ann. Chem. 1985, 1985, 1557–1569. [Google Scholar] [CrossRef]
  26. Conradie, M.M.; Muller, A.J.; Conradie, J. Thienyl-containing β-Diketones: Synthesis, Characterization, Crystal Structure and Keto-enol Kinetics. S. Afr. J. Chem. 2008, 61, 13–21. [Google Scholar]
  27. Su, B.; Hou, Y.; Wang, L.; Li, X.; Pan, D.; Yan, T.; Zhang, A.; Paison, F.; Ding, L. The Syntheses, Characterization and Crystal Structure of a Series of Heterocyclic β-diketones and their Isoxazole Compounds. Curr. Org. Synth. 2019, 16, 1174–1184. [Google Scholar] [CrossRef] [PubMed]
  28. Taydakov, I.V.; Kreschchenova, Y.M.; Dolotova, E.P. A convenient and practical synthesis of β-diketones bearing linear perfluorinatd alkyl groups and a 2-thienyl moiety. Beilstein J. Org. Chem. 2018, 14, 3106–3111. [Google Scholar] [CrossRef] [PubMed]
  29. Bunting, J.W.; Kanter, J.P.; Nelander, R.; Wu, Z. The acidity and tautomerism of β-diketones in aqueous solution. Can. J. Chem. 1995, 73, 1305–1311. [Google Scholar] [CrossRef]
  30. Manolova, Y.; Deneva, V.; Antonov, L.; Drakalska, E.; Momekova, D.; Lambov, N. The effect of the water on the curcumin tautomerism: A quantitative approach. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2014, 132, 815–820. [Google Scholar] [CrossRef] [PubMed]
  31. Murphy, R.B.; Staton, J.; Rawal, A.; Darwish, T.A. The effect of deuteration on the keto-enol equilibrium and photostability of the sunscreen agent avoenzone. Photochem. Photobiol. Sci. 2020, 19, 1410–1422. [Google Scholar] [CrossRef] [PubMed]
  32. Verma, P.K.; Steinbacher, A.; Koch, F.; Nuernberger, P.; Brixner, T. Monitoring ultrafast intramolecular processes in an unsymmetrical β-diketone. Phys. Chem. Chem. Phys. 2015, 17, 8459–8466. [Google Scholar] [CrossRef]
  33. Alagona, G.; Ghio, C. Keto-enol tautomerism in linear and cyclic β-diketones: A DFT study in vacuo and in solution. Int. J. Quantum Chem. 2008, 108, 1840–1855. [Google Scholar] [CrossRef]
  34. Sharma, R.K.; Jahnke, P.J. Acidity of usnic acid. Indian J. Chem. 1966, 4, 16–18. [Google Scholar]
  35. Iglesias, E.; Ojea-Cao, V.; García-Rio, L.; Ramón Leis, J. Effects of β-Cyclodextrin on the Keto-Enol Equilibrium of Benzoylacetone and on Enol Reactivity. J. Org. Chem. 1999, 64, 3954–3963. [Google Scholar] [CrossRef]
  36. Drakalska, E.; Momekova, D.; Manolova, Y.; Budurova, D.; Momekov, G.; Genova, M.; Antonov, L.; Lambov, N.; Rangelov, S. Hybrid liposomal PEGylated calix[4]arene systems as drug delivery platforms for curcumin. Int. J. Pharma. 2014, 472, 165–174. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Angelova, S.; Antonov, L. Molecular Insight into Inclusion Complex Formation of Curcumin and Calix[4]arene. Chemistryselect 2017, 2, 9652–9658. [Google Scholar] [CrossRef]
  38. Becke, A.D. Density-functional exchange-energy approximation with correct asymptotic behavior. Phys. Rev. A 1988, 38, 3098–3100. [Google Scholar] [CrossRef]
  39. Spanget-Larsen, J.; Hansen, B.K.V.; Hansen, P.E. OH stretching frequencies in systems with intramolecular hydrogen bonds: Harmonic and anharmonic analyses. Chem. Phys. 2011, 389, 107–115. [Google Scholar] [CrossRef]
  40. Hansen, P.E.; Spanget-Larsen, J. Prediction of OH stretching frequencies in systems with intramolecular hydrogen bonds. J. Mol. Struct. 2012, 1018, 8–13. [Google Scholar] [CrossRef]
  41. Hansen, P.E.; Jezierska, A.; Panek, J.; Spanget-Larsen, J. Theoretical calculations are a strong tool in the investigation of strong intramolecular hydrogen bonds. In Molecular Spectroscopy. A Quntum Chemical Approach; Ozaki, Y., Wojcik, M., Popp, J., Eds.; Wiley-VCH: Weinheim, Germany, 2019. [Google Scholar]
  42. Carlsen, L.; Hansen, P.E.; Saeed, B.A.; Elias, R.S. Curcumin analogues for possible cancer treatment. A QSAR study. World J. Biol. Pharm. Res. 2021, 1, 1–16. [Google Scholar] [CrossRef]
  43. Puglisi, A.; Giovanni, T.; Antonov, L.; Cappelli, C. Interplay between conformationl and solvent effects in UV-visible absorption spectra: Curcumin tautomers as a case study. Phys. Chem. Chem. Phys. 2019, 21, 15504–15514. [Google Scholar] [CrossRef] [PubMed]
  44. Caruso, F.; Pettinari, C.; Marchetti, F.; Rossi, M.; Opazo, C.; Kumar, S.; Balwahni, S.; Ghosh, G. Inhibitory effect of β-diketones and their metal complexes on TNF-a induced expression of ICAM-a on human endothelial cells. Bioorganic Med. Chem. 2009, 17, 6166–6171. [Google Scholar] [CrossRef] [PubMed]
  45. Klamt, A.; Schuurmann, G.J. COSMO—A new approach to dielectric screening in solvents with explicit expression for the screening energy and its gradient. J. Chem. Soc. Perkin Trans. 1993, 2, 799–805. [Google Scholar] [CrossRef]
  46. Porchezhiyan, V.; Kalaivani, D.; Shobana, J.; Noorjahan, S.E. Synthesis, docking and in vitro evaluation of L-proline derived 1,3-diketones possessing anti-cancer and anti-inflammatory activities. J. Mol. Struct. 2020, 1206, 127754. [Google Scholar] [CrossRef]
  47. Dhoke, G.V.; Loderer, C.; Davari, M.D.; Ansorge-Schumacher, M.; Schwaneberg, U.; Bocola, M. Activity prediction of substrates in NADH-dependent carbonyl reductase by docking requires catalytic constraints and charge parameterization of catalytic zinc environment. J. Comput. Aided Mol. Des. 2015, 29, 1057–1069. [Google Scholar] [CrossRef] [PubMed]
  48. Zusso, M.; Mercanti, G.; Belluti, F.; Martino, R.M.C.D.; Pagetta, A.; Marinelli, C.; Brun, P.; Ragazzi, E.; Lo, R.; Stifani, S.; et al. Phenolic 1,3-diketones attenuate lipopolysaccharide-induced inflammatory response by an alternative magnesiummediated mechanism. Br. J. Pharmacol. 2017, 174, 1090–1103. [Google Scholar] [CrossRef] [Green Version]
  49. Tyrrell, E.; Archer, R.; Sinner, G.A.; Sign, K.; Colston, K.; Driver, C. Structure elucidation and an investigation into the in vitro effects of hop acids on human cancer cells. Phytochem. Lett. 2010, 3, 17–23. [Google Scholar] [CrossRef]
  50. Derogis, P.B.; Martins, F.T.; de Souza, T.C.; de, C.; Moreira, M.E.; Souza, J.D.F.; Doriguetto, A.C.; de Souza, K.R.; Veloso, M.P.; Dos Santos, M.H. Complete assignment of the 1H NMR and 13C spectra of Garciniaphenone and keto-enol equlibrium statement for prenylated benzophenones. Magn. Reson. Chem. 2008, 46, 278–282. [Google Scholar] [CrossRef]
  51. Martins, F.T.; Camps, I.; Doriguoetto, A.C.; dosSantos, M.H.; Ellena, J.; Bobosa, L.C.A. Crystal structure of Garciniaphenone on the Relationship between Keto-enol Tautomerism and Configuration. Helv. Chim. Acta 2008, 91, 1313–1316. [Google Scholar] [CrossRef]
  52. dos Santos, M.H.; Nagem, T.J.; Braz-Filho, R.; Lula, I.S.; Speziali, N.L. Complete assignment of the 1H and 13C NMR spectra of the tetraisoprenylated benzophenone 15-epiclusianone. Magn. Reson. Chem. 2001, 39, 155–159. [Google Scholar] [CrossRef]
  53. Lage, M.R.; Morbec, J.M.; Santos, M.H.; Carneiro, J.W.dM.; Costa, L.T. Natural polyprenylated benzophenone: Keto-enol tautomerism from density functional calculations and the AIM theory. J. Mol. Model. 2017, 23, 140. [Google Scholar] [CrossRef] [PubMed]
  54. Martins, F.T.; Cruz, J.W., Jr.; Derogis, P.B.M.C.; dos Santos, M.H.; Veloso, M.P.; Ellena, J.; Doriguetto, A.C. Natural Polyprenylated Benzophenones: Keto-Enol Tautomerism and Stereochemistry. Braz. Chem. Soc. 2007, 18, 1515–1523. [Google Scholar] [CrossRef] [Green Version]
  55. Martins, F.T.; Assis, D.M.; dos Santos, M.H.; Camps, I.; Veloso, M.P.; Juliano, M.A.; Alves, L.C.; Doriguetto, A.C. Natural polyprenylated benzophenones inhibiting cysteine and serine proteases. Eur. J. Med. Chem. 2009, 44, 1230–1239. [Google Scholar] [CrossRef] [PubMed]
  56. Vidal-Albalat, A.; González, F.V. Natural Products as Cathepsin Inhibitors. In Studies in Natural Products Chemistry; Atta-ur-Rahman, Ed.; Elsevier: Amsterdam, The Netherlands, 2016; Volume 50, pp. 179–213. [Google Scholar]
  57. Singh, J.; Rossiter, S.; Bassin, J.; Goyal, M. Synthesis, Antimicrobacterial Activity Evaluation and Mode of Action of Series of 1,3-Diketones. In Proceedings of the 27th European Congrss on Clinical Microbiology and Infectious Diseases, Vienna, Austria, 22–25 April 2017. [Google Scholar]
  58. Pan, M.-H.; Huang, M.-C.; Wang, Y.-J.; Lin, J.-K.; Lin, C.-H. Induction of Apotosis by Didroxydibenzoylmethane through Coordinative Modulation of Cyclin D3, Bcl-XL and Bax, Release of Cyctochrome c and Sequential Activation of Caspases in Human Colorectal Carcinoma Cells. J. Agric. Food Chem. 2003, 51, 3977–3984. [Google Scholar] [CrossRef] [PubMed]
  59. Lin, C.-C.; Liu, Y.; Ho, C.-T.; Huang, M.-T. Inhibitory effects of 1,3-bis-(2-substituted-phenyl)-propane,1,3-dine, β-diketone structural analogues of curcumin, on chemical-induced tumor promotion and inflammation in mouse skin. Food Funct. 2011, 2, 78–83. [Google Scholar] [CrossRef] [PubMed]
  60. Ali, N.M.; Yeap, S.K.; Abu, N.; Lim, K.L.; Ky, H.; Pauzi, A.Z.M.; Ho, W.Y.; Tan, S.W.; Alan-Ong, H.K.; Zareen, S.; et al. Synthetic curcumin derivative DK1 possessed G2/M arrest and induced apoptosis through accumulation of intracellullar ROS in MCF-7 breas cancer cells. Cancer Cell. Int. 2017, 17, 30. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  61. Mbese, Z.; Khwaza, V.; Aderibigbe, B.A. Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and breast Cancers. Molecules 2019, 24, 4386. [Google Scholar] [CrossRef] [Green Version]
  62. Amalraj, A.; Pius, A.; Gopi, S.; Gopi, S. Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives. A review. J. Trad. Complement. Med. 2017, 7, 205–233. [Google Scholar] [CrossRef] [Green Version]
  63. Priyadarsini, K.I. Chemical and Structural Features Influencing the Biological Activity of Curcumin. Curr. Pharm. Design 2013, 19, 2093–2100. [Google Scholar] [PubMed]
  64. Hewlings, S.J.; Kalman, D.S. Curcumin: A Review of Its’ Effects on Human Health. Foods 2017, 6, 92. [Google Scholar] [CrossRef] [PubMed]
  65. Mansouri, K.; Rasoulpoor, S.; Daneshkhah, A.; Abolfathi, S.; Salari, N.; Mohammadi, M.; Rasoulpoor, S.; Shabani, S. Clinical effects of curcumin in enhancing cancer therapy: A systematic review. BMC Cancer 2020, 20, 791. [Google Scholar] [CrossRef]
  66. Banik, U.; Parasuraman, S.; Adhikary, A.K.; Othman, N.H. Curcumin: The spicy modulator of breast carcinogenesis. J. Exp. Clin. Cancer Res. 2017, 36, 119. [Google Scholar] [CrossRef] [Green Version]
  67. Schneider, C.; Gordon, O.N.; Edwards, R.L.; Luis, P.B. Degradation of Curcumin: From Mechanism to Biological Implications. J. Agric. Food Chem. 2015, 63, 7606–7614. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  68. Shen, L.; Liu, C.-C.; An, C.-Y.; Ji, H.-F. How does curcumin work with poor bioavailability? Clues from experimental and theoretical studies. Sci. Rep. 2016, 6, 20872. [Google Scholar] [CrossRef] [Green Version]
  69. Lopresti, A.L. The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects? Adv. Nutr. 2018, 9, 41–50. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Rinwa, P.; Kumar, A. Piperine potentiates the protective effects of curcumin against chronic unpredictable stress-induced cognitive impairment and oxidative damage in mice. Brain Res. 2012, 1488, 38–50. [Google Scholar] [CrossRef] [PubMed]
  71. Schobert, R.; Schlenk, A. Tetramic and tetronic acids: An update on new derivatives and biological aspects. Bioorg. Med. Chem. 2008, 16, 4203–4221. [Google Scholar] [CrossRef] [PubMed]
  72. Hofmann, J.P.; Hansen, P.E.; Bond, A.D.; Duus, F. Tautomerism in 3-Acyltetronic Acids Revisited. A Spectrochemometric Approach to Tautomerism and Hydrogen-Bonding. J. Mol. Struct. 2006, 790, 80–88. [Google Scholar] [CrossRef]
  73. Wang, J.-F.; Qin, X.; Xu, F.Q.; Zhang, T.; Liao, S.; Lin, X.; Yang, B.; Liu, J.; Wang, L.; Tu, Z.; et al. Tetramic acid derivatives and polyphenols from sponge-derived fungus and their biological evaluation. Nat. Prod. Res. 2015, 29, 1761–1765. [Google Scholar] [CrossRef] [PubMed]
  74. Wang, J.; Yao, Q.F.; Amin, M.; Nong, X.H.; Zhang, X.Y.; Qi, S.H. Penicillenols from a deep-sea fungus Aspergillus restrictus inhibit Candida albicans biofilm formation and hyphal growth. J. Antibiot. 2017, 70, 763–770. [Google Scholar] [CrossRef] [Green Version]
  75. Matiadis, D. Metal-catalysed and metal–Mediated Approaches to the Synthesis and Functionalization of Tetramic acids. Catalysts 2019, 9, 50. [Google Scholar] [CrossRef] [Green Version]
  76. Cherian, P.T.; Wu, X.; Maddox, M.M.; Singh, A.P.; Lee, R.E.; Hurdle, J.G. Chemical Modulation of the Biological Activity of Reutericyclin: A Membrane-Active Antibiotic from Lactobacillusreuteri. Sci. Rep. 2014, 4, 4721. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Cherian, P.T.; Deshpande, A.; Cheramie, M.N.; Bruhn, D.F.; Hurdle, J.G.; Lee, R.E. Design, synthesis and microbiological evaluation of ampicillin-tetramic acid hybrid antibiotics. J. Antibiot. 2017, 70, 65–72. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  78. Oh, J.; Quan, K.T.; Lee, J.S.; Park, I.; Kim, C.S.; Ferreira, D.; Thuong, P.T.; Kim, Y.H.; Na, M. NMR-Based Investigation of Hydrogen Bonding in a Dihydroanthracen-1(4H)one from Rubia philippinensis and Its Soluble Epoxide Hydrolase Inhibitory Potential. J. Nat. Prod. 2018, 81, 2429–2435. [Google Scholar] [CrossRef] [PubMed]
  79. Radulovi´c, N.K.; Genci´c, M.S.; Stojanovi´c, N.M.; Randjelovi´c, P.J. Prenylatd β-diketones, two new additions to the family of biologically active Hypericum perforator L. (Hypericaceae) secondary metabolites. Food Chem. Toxicol. 2018, 118, 505–513. [Google Scholar] [CrossRef]
  80. Tian, J.; Zhang, F.; Cheng, J.; Guo, S.; Liu, P.; Wang, H. Antidepressant like activity of adhyperforin, a novel constituent of Hypericum Perforatum L. Sci. Rep. 2014, 4, 5632. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  81. Luzina, O.A.; Salakhutdinov, N.F. Usnic acid and its derivatives for pharmaceutical use: A patent review (2000–2017). Expert Opin. Ther. Pat. 2018, 28, 477–491. [Google Scholar] [CrossRef] [PubMed]
  82. Luzina, O.; Filimonov, A.; Zakharenko, A.; Chepanova, A.; Zakharova, O.; Ilina, E.; Dyrkheeva, N.; Likhatskaya, G.; Salakhutdinov, N.; Lavrik, O.; et al. Usnic Acid Conjugates with Monoterpenoids as Potent Tyrosyl-DNA Phosphodiesterase 1 Inhibitors. Nat. Prod. 2020, 83, 320–2329. [Google Scholar] [CrossRef]
  83. Kristmundsdóttir, T.; Aradóttir, H.A.; Ingólfsdóttir, K.; Ogmundsdóttir, H.M. Solubilization of the lichen metabolite (+)-usnic acid for testing in tissue culture. J. Pharm. Pharmacol. 2002, 54, 1447–1452. [Google Scholar] [CrossRef]
  84. Francolini, I.; Taresco, V.; Crisante, F.; Martinelli, A.; D’Ilario, L.; Piozzi, A. Water Soluble Usnic Acid-Polyacrylamide Complexes with Enhanced Antimicrobial Activity against Staphylococcus epidermidis. Int. J. Mol. Sci. 2013, 14, 7356–7369. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Rauschenbach, M.; Lawrenson, S.B.; Taresco, V.; Pearce, A.K.; O’Reilly, R.K. Antimicrobial Hyperbranched Polymer–Usnic Acid Complexes through a Combined ROP-RAFT Strategy. Macromol. Rapid Commun. 2020, 41, e2000190. [Google Scholar] [CrossRef] [PubMed]
  86. Lukáč, M.; Prokipčák, I.; Lacko, I.; Devínsky, F. Solubilisation (+)-usnic acid in aqueous micellar solutions of gemini and heterogemini surfactants and their equimolar mixture. Acta Fac. Pharm. Univ. Comen. 2012, 59, 36–43. [Google Scholar] [CrossRef] [Green Version]
  87. Pandey, S.; Misra, S.K.; Sharma, N. Synthesis and characterization of graphene-usnic acid conjugate microspheres and its antibacterial activity against staphylococcus Aureus. Int. J. Pharm. Sci. Res. 2018, 59, 939–946. [Google Scholar]
  88. Yang, Y.; Bae, W.K.; Lee, J.-Y.; Choi, Y.J.; Lee, K.H.; Park, M.S.; Yu, Y.H.; Park, S.-Y.; Zhou, R.; Taş, İ.; et al. Potassium usnate, a water-soluble usnic acid salt, shows enhanced bioavailability and inhibits invasion and metastasis in colorectal cancer. Sci. Rep. 2018, 8, 16234. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Classification of β-diketones. (a) lbdk type of β-diketones, (b) cbdk type, and (c) dbdk type.
Figure 1. Classification of β-diketones. (a) lbdk type of β-diketones, (b) cbdk type, and (c) dbdk type.
Pharmaceuticals 14 01189 g001
Figure 2. (a) (2Z,4E)-1-(4-Chloro-2-hydroxyphenyl)-5-(3,4-dimethoxyphenyl)-3-hydroxypenta-2,4-dien-1-one; (b) didesmethoxycurcumin.
Figure 2. (a) (2Z,4E)-1-(4-Chloro-2-hydroxyphenyl)-5-(3,4-dimethoxyphenyl)-3-hydroxypenta-2,4-dien-1-one; (b) didesmethoxycurcumin.
Pharmaceuticals 14 01189 g002
Figure 3. Deuterium isotope effects on 13C chemical shifts. They are defined as nΔ = δCx(H) − δCx(D). n is the number of bonds between the label (deuterium) and the nucleus in question, Cx. The isotope effects given are color-coded to refer to the deuterium causing the effect. Data were taken from [11] with permission from Elsevier.
Figure 3. Deuterium isotope effects on 13C chemical shifts. They are defined as nΔ = δCx(H) − δCx(D). n is the number of bonds between the label (deuterium) and the nucleus in question, Cx. The isotope effects given are color-coded to refer to the deuterium causing the effect. Data were taken from [11] with permission from Elsevier.
Pharmaceuticals 14 01189 g003
Figure 4. Enolic forms of usnic acid. Enolic proton marked with red.
Figure 4. Enolic forms of usnic acid. Enolic proton marked with red.
Pharmaceuticals 14 01189 g004
Figure 5. 1H NMR spectra of curcumin in a mixture of H2O and DMSO-d6. From top, 0%, 25%, 50%, 55% H2O. The major form is the enol-form. The diketo-form is seen as the minor resonances.
Figure 5. 1H NMR spectra of curcumin in a mixture of H2O and DMSO-d6. From top, 0%, 25%, 50%, 55% H2O. The major form is the enol-form. The diketo-form is seen as the minor resonances.
Pharmaceuticals 14 01189 g005
Figure 6. Benzoylacetone complexation with β-cyclodextrin. E refers to enol- and K to diketo-form. Taken from [35] with permission from the American Chemical Society.
Figure 6. Benzoylacetone complexation with β-cyclodextrin. E refers to enol- and K to diketo-form. Taken from [35] with permission from the American Chemical Society.
Pharmaceuticals 14 01189 g006
Figure 7. Top: One enol-form of HQPh and the preferred tautomer docked to the ICAM-1 protein from [44]. With permission from Elsevier. Bottom: β-Diketones derived from L-proline. R can be phenyl, p-toluene, p-Cl, Br, I-phenyl, 2,4-difluoro- and 2,4-dichorophenyl, 2-fluoro-4-bromo- and 2-methyl-4-iodophenyl, and 2-furanyl and 2-naphthyl-6-methoxy. Docking of the latter in the binding site of PTK6. (a). Showing the docking. (b). Showing the amino acid involved. Taken from [46] with permission from Elsevier.
Figure 7. Top: One enol-form of HQPh and the preferred tautomer docked to the ICAM-1 protein from [44]. With permission from Elsevier. Bottom: β-Diketones derived from L-proline. R can be phenyl, p-toluene, p-Cl, Br, I-phenyl, 2,4-difluoro- and 2,4-dichorophenyl, 2-fluoro-4-bromo- and 2-methyl-4-iodophenyl, and 2-furanyl and 2-naphthyl-6-methoxy. Docking of the latter in the binding site of PTK6. (a). Showing the docking. (b). Showing the amino acid involved. Taken from [46] with permission from Elsevier.
Pharmaceuticals 14 01189 g007aPharmaceuticals 14 01189 g007b
Figure 8. Tautomeric forms, (a,d) are ditketo forms, (b,c) are enol forms of 4-benzoyl-3-methyl-1-phenylpyrazol-5-one (HQPh). From [44].
Figure 8. Tautomeric forms, (a,d) are ditketo forms, (b,c) are enol forms of 4-benzoyl-3-methyl-1-phenylpyrazol-5-one (HQPh). From [44].
Pharmaceuticals 14 01189 g008
Figure 9. Lupulone, R is equal to isoprene. (a,b) are different positional enol isomers.
Figure 9. Lupulone, R is equal to isoprene. (a,b) are different positional enol isomers.
Pharmaceuticals 14 01189 g009
Figure 10. Tautomeric equilibrium of garciniaphenone (R = isoprenyl and R1 = methyl) and 7-epi-clusianone (R = isoprenyl, R1 = H). (a,b) are different positional enol isomers.
Figure 10. Tautomeric equilibrium of garciniaphenone (R = isoprenyl and R1 = methyl) and 7-epi-clusianone (R = isoprenyl, R1 = H). (a,b) are different positional enol isomers.
Pharmaceuticals 14 01189 g010
Figure 11. 1-(2-Hydroxyphenyl)-3-phenyl-1,3-propanedione (o-hydroxydibenzoylmethane). For an example of the diketo-form, see Figure 1. (a,b) are enolforms. The enolic proton is in red.
Figure 11. 1-(2-Hydroxyphenyl)-3-phenyl-1,3-propanedione (o-hydroxydibenzoylmethane). For an example of the diketo-form, see Figure 1. (a,b) are enolforms. The enolic proton is in red.
Pharmaceuticals 14 01189 g011
Figure 12. Analogues of curcumin and isocurcumin.
Figure 12. Analogues of curcumin and isocurcumin.
Pharmaceuticals 14 01189 g012
Figure 13. Ranking of the 23 enol- (blue triangles) and 23 diketo (red diamonds)-forms according to their calculated prostate cancer treatment (PCT) ability. H1,H2 etc. refer to Table 4. For comparison, the values for the enol-form (eC1) and the diketo-form (kC1) of curcumin is included. Taken from [42].
Figure 13. Ranking of the 23 enol- (blue triangles) and 23 diketo (red diamonds)-forms according to their calculated prostate cancer treatment (PCT) ability. H1,H2 etc. refer to Table 4. For comparison, the values for the enol-form (eC1) and the diketo-form (kC1) of curcumin is included. Taken from [42].
Pharmaceuticals 14 01189 g013
Figure 14. Tautomeric equilibria of 3-acyl tetronic (X=O) and tetramic (X=N) acids. (ad) are the different enolic forms.
Figure 14. Tautomeric equilibria of 3-acyl tetronic (X=O) and tetramic (X=N) acids. (ad) are the different enolic forms.
Pharmaceuticals 14 01189 g014
Figure 15. Reutericyclin. (a,b) are two different enolic forms.
Figure 15. Reutericyclin. (a,b) are two different enolic forms.
Pharmaceuticals 14 01189 g015
Figure 16. Structure of Rubia philippinensis as suggested in [78].
Figure 16. Structure of Rubia philippinensis as suggested in [78].
Pharmaceuticals 14 01189 g016
Figure 17. Hyperforin (top) and adhyperforin (bottom).
Figure 17. Hyperforin (top) and adhyperforin (bottom).
Pharmaceuticals 14 01189 g017
Table 1. 1H chemical shifts of CH2, CH, and OH protons and enol percentage. From [24] with permission from the American Chemical Society.
Table 1. 1H chemical shifts of CH2, CH, and OH protons and enol percentage. From [24] with permission from the American Chemical Society.
Compound/Chemical Shifts a and % Enol DiketoEnolOH% Enol
2,4-Pentanedione3.585.5015.3479
2,4-Hexanedione3.18 b5.08 b13.46 b81
5-Methyl-3,5-hexanedione3.575.5014.9280
2,2-Dimethyl-3,5-hexanedione3.565.6015.5894
3,5-Heptanedione3.665.6615.0476
3,5-Heptanedione3.18 b5.12 b14.30 b76
2-Methyl-3,5-heptanedione3.575.5014.9288
2,2-Dimethyl-3,5-heptanedione3.565.5815.8892
2,6-Dimetyl-3,5-heptanedione3.605.5015.5094
2,2,6-Trimethyl-3,5-heptanedione3.54 b5.28 b15.52 b96
2,2,6,6-Tetramethyl-3,5-heptanedione3.745.86cc
a Chemical shifts in ppm from internal TMS. b Chemical shifts in ppm from external TMS. c No data given.
Table 2. β-Diketones with aromatic and heteroaromatic substituents. Solvent CDCl3. Percentage of enol-form a.
Table 2. β-Diketones with aromatic and heteroaromatic substituents. Solvent CDCl3. Percentage of enol-form a.
R1 bR2% EnolReference
CH32-Thiophene84, 94.4[26,27]
C3F72-Thiophene100[28]
2-Thiophene2-Thiophene82[26,27]
Ph2-Thiophene94.3, 92.8[27]
CF32-Thiophene94.4[26]
Ph2-Furane95.5[27]
a See also Table 3 and the paper by Sloop et al. above [19]. b R1 and R2 refer to Figure 1.
Table 3. pKa values and equilibrium constants for enol to keto-forms. Data from [29] with permission from Canadian Science Publication.
Table 3. pKa values and equilibrium constants for enol to keto-forms. Data from [29] with permission from Canadian Science Publication.
R1 aR2pKae bpKakKe c
CH3CH38.038.710.21
PhPh8.64≈7.9≈6
3-Py3-Py7.046.781.8
4-Py4-Py5.45≈4.65≈6
CH3Ph8.398.530.72
CH33-Py7.157.470.48
CH34-Py7.167.001.4
Ph3-Py7.377.261.3
Ph4-Py7.27-3
a R1 and R2 refer to Figure 1. b e and k refer to enol- and diketo-forms. c Ke is defined as Ke = [eH]/[kH].
Table 4. Substitution patterns for the curcumin analogues.
Table 4. Substitution patterns for the curcumin analogues.
R1 aR2R3R4 R1 aR2R3R4
H1HHHHOH1OHHHH
H2BrHHHOMe1HHOMeOMe
H3FHHHOMe2BrHOMeOMe
H4ClHHHOMe3FHOMeOMe
H5OMeHHHOMe4ClHOMeOMe
H6N(Me)2HHHOMe5OMeHOMeOMe
H7HClHHOMe6N(Me)2HOMeOMe
H8BrClHHOMe7HClOMeOMe
H9FClHHOMe8BrClOMeOMe
H10ClClHHOMe9FClOMeOMe
H11OMeClHHOMe10ClClOMeOMe
H12N(Me)2ClHHOMe11OMeClOMeOMe
H13HMeHHOMe12N(Me)2ClOMeOMe
H14BrMeHHOMe13HMeOMeOMe
H15FMeHHOMe14BrMeOMeOMe
H16ClMeHHOMe15FMeOMeOMe
H17OMeMeHHOMe16ClMeOMeOMe
H18N(Me)2MeHHOMe17OMeMeOMeOMe
iC1OMeHOHHOMe18N(Me)2MeOMeOMe
iC2OMeClOHHOH2OHHOMeOMe
iCOmeMeOHHC1OHHOMeH
a. R´s refer to Figure 12.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Hansen, P.E. Structural Studies of β-Diketones and Their Implications on Biological Effects. Pharmaceuticals 2021, 14, 1189. https://doi.org/10.3390/ph14111189

AMA Style

Hansen PE. Structural Studies of β-Diketones and Their Implications on Biological Effects. Pharmaceuticals. 2021; 14(11):1189. https://doi.org/10.3390/ph14111189

Chicago/Turabian Style

Hansen, Poul Erik. 2021. "Structural Studies of β-Diketones and Their Implications on Biological Effects" Pharmaceuticals 14, no. 11: 1189. https://doi.org/10.3390/ph14111189

APA Style

Hansen, P. E. (2021). Structural Studies of β-Diketones and Their Implications on Biological Effects. Pharmaceuticals, 14(11), 1189. https://doi.org/10.3390/ph14111189

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop